Purchase Order 75D30122P13764
Award Date 5/9/22
Potential Completion Date 5/31/22
Potential Value $241K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $20,634.75 contract is for the provision of ILLUMINA REAGENTS to support the agency's research and diagnostic activities. Illumina has a history of providing sequencing systems, consumables, and services to federal agencies like the NIH, USDA, and VA....
- This federal contract was awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Illumina, Inc. to provide laboratory supplies. The contract has a potential value of $190,565.60 and was awarded on a firm fixed price basis with no set-aside designation. Illumina is a for-profit manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The company has previously received prime federal contract awards from...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, for ILLUMINA ISEQ 100 I1 REAGENT. The potential value of this contract is $9,991.97. This award is not associated with any larger contract vehicle and does not have a set-aside designation. Illumina has previously provided sequencing systems, reagents,...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $85,056.40 contract is for the delivery of laboratory reagents, with an ultimate completion date of July 31, 2022. The contract does not have a set-aside designation. Illumina has previously received federal prime contract and subcontract awards from agencies like the National...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, for the provision of lab supplies and reagents. The $149,220.97 contract does not have a set-aside designation and is intended to support the CDC's research and diagnostics needs in Atlanta, Georgia. Illumina has a history of providing a range of...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the provision of an ILLUMINA NS 1000 INSTRUMENT. The potential value of this award is $205,800.00. Illumina has previously received prime federal contract awards from various agencies like the NIH, CDC, USDA, and VA to provide a range of genomic sequencing systems, consumables, and...
- The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $247,008.03 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The contract is for the provision of laboratory supplies, with a completion date of May 31, 2024. Illumina has previously received federal awards from agencies such as the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Blanket Purchase Agreement (BPA) call to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The one-year contract, valued at $120,159.72, is for the delivery of reagent kits on a firm fixed-price basis. The award does not include any set-aside provisions. Illumina has previously supported federal agencies such as the National Institutes of...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for reagents to be used with Illumina's sequencing systems. The $219,192.00 contract does not have a set-aside designation and is intended to support the CDC's needs through August 31, 2022. Illumina has a history of providing sequencing equipment, consumables, and services to...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $144,302.41 contract provides supplies - chemicals to support the agency's research and diagnostics needs. This award does not have a set-aside designation. Illumina has previously been awarded prime federal contracts by agencies such as NIH, USDA,...